We are live on
!
Find out more
FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
1-Year Est. Return
44.84%
This Fund
S&P 500
This Quarter
Est. Return
+0.09%
1 Year Est. Return
+44.84%
3 Year Est. Return
-66.21%
5 Year Est. Return
-36.36%
10 Year Est. Return
–
AUM
$39.6M
AUM Growth
+$35.4K
(+0.09%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
10x Genomics
TXG
$5.87B
| $39.6M | 100% |
708,528
| – | – |
|
Similar funds
AG
SAM
AC
QI
TAAM
NAM
MSKCC
BRC
Foresite Capital Management II's Q2 2023 Portfolio in Review
As of Q2 2023, Foresite Capital Management II held 1 position worth $39.6M, up 0.09% from $39.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 0%. Foresite Capital Management II opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Foresite Capital Management II's ten largest holdings make up 100% of its $39.6M portfolio in Q2 2023.
- Foresite Capital Management II opened 0 new positions and closed 0 in Q2 2023.
- Foresite Capital Management II's portfolio value rose 0.09% quarter-over-quarter to $39.6M.
Based on Foresite Capital Management II's 13F filing for Q2 2023, filed 11 Aug 2023.